X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PLETHICO PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PLETHICO PHARMA STERLING BIOTECH/
PLETHICO PHARMA
 
P/E (TTM) x -1.9 -1.1 - View Chart
P/BV x 0.1 0.0 441.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PLETHICO PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PLETHICO PHARMA
Mar-14
STERLING BIOTECH/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs11395 2.7%   
Low Rs331 10.9%   
Sales per share (Unadj.) Rs26.8604.4 4.4%  
Earnings per share (Unadj.) Rs-15.032.5 -46.1%  
Cash flow per share (Unadj.) Rs-5.551.3 -10.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9473.6 11.6%  
Shares outstanding (eoy) m267.8734.08 786.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 73.5%   
Avg P/E ratio x-0.56.6 -7.1%  
P/CF ratio (eoy) x-1.34.2 -30.6%  
Price / Book Value ratio x0.10.5 28.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,262 25.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5471,596 34.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18120,598 34.9%  
Other income Rs m43386 11.0%   
Total revenues Rs m7,22320,984 34.4%   
Gross profit Rs m9472,818 33.6%  
Depreciation Rs m2,543642 396.0%   
Interest Rs m4,3771,593 274.7%   
Profit before tax Rs m-5,931969 -612.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-138 1,390.6%   
Profit after tax Rs m-4,0071,107 -362.0%  
Gross profit margin %13.213.7 96.4%  
Effective tax rate %32.4-14.3 -227.1%   
Net profit margin %-55.85.4 -1,038.3%  
BALANCE SHEET DATA
Current assets Rs m14,33518,877 75.9%   
Current liabilities Rs m49,80911,896 418.7%   
Net working cap to sales %-494.033.9 -1,457.8%  
Current ratio x0.31.6 18.1%  
Inventory Days Days40336 1,122.5%  
Debtors Days Days171198 86.3%  
Net fixed assets Rs m55,4329,861 562.2%   
Share capital Rs m268341 78.6%   
"Free" reserves Rs m13,93512,331 113.0%   
Net worth Rs m14,70116,139 91.1%   
Long term debt Rs m9,4784,706 201.4%   
Total assets Rs m73,98833,146 223.2%  
Interest coverage x-0.41.6 -22.1%   
Debt to equity ratio x0.60.3 221.1%  
Sales to assets ratio x0.10.6 15.6%   
Return on assets %0.58.1 6.1%  
Return on equity %-27.36.9 -397.4%  
Return on capital %-6.412.3 -52.3%  
Exports to sales %25.921.4 121.2%   
Imports to sales %0.215.2 1.1%   
Exports (fob) Rs m1,8604,402 42.2%   
Imports (cif) Rs m123,136 0.4%   
Fx inflow Rs m1,8604,402 42.2%   
Fx outflow Rs m253,184 0.8%   
Net fx Rs m1,8351,219 150.6%   
CASH FLOW
From Operations Rs m1,7192,437 70.5%  
From Investments Rs m-3,148-6,265 50.3%  
From Financial Activity Rs m1,4262,490 57.3%  
Net Cashflow Rs m-3-1,337 0.3%  

Share Holding

Indian Promoters % 33.9 82.7 41.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 9.9 5.5 180.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 7.5 524.0%  
Shareholders   21,482 10,665 201.4%  
Pledged promoter(s) holding % 55.9 85.7 65.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  PANACEA BIOTECH  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jan 17, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - PLETHICO PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS